Search

everythinglearnresearchcommunity

for

Search:↓

Rimegepant causes more nausea and skin issues, while ubrogepant causes more muscle issues; personalized treatment is important.

Dutasteride is more effective than finasteride for hair growth, and pregabalin effectively treats neuropathic pain.

Tofacitinib improved hair and nail conditions in a teen with alopecia areata.

Baricitinib effectively regrows hair in severe alopecia areata cases.

The Trust tonic is more effective than minoxidil for treating hair loss.

Tofacitinib effectively treats Alopecia Areata.

New treatments for cancer and skin disorders show promise in disrupting harmful cell interactions and promoting hair growth.

Herbal compounds like ricinoleic acid, quercetin-3-O-rutinoside, and hinokiflavone may be safe and effective for treating hair loss.

Sodium Valproate nanospanlastics could be a safe and effective treatment for Androgenic Alopecia, with fewer side effects than minoxidil.

Upadacitinib may effectively treat twenty-nail dystrophy without causing pain.

New steroidal compounds could be effective for treating conditions related to 5α-reductase enzyme activity.

A man with severe hair loss regrew all his hair using tofacitinib and stayed healthy for a year.

RT1640 treatment reverses gray hair and promotes hair growth in mice.

Platycladi Cacumen may help treat hair loss by affecting certain biological pathways.

Sustained-release sodium valproate is effective in treating epilepsy, with some side effects influenced by genetics.

Cyproterone acetate improves skin symptoms and quality of life in women with androgen-related issues.

Using existing drugs for new treatments is cost-effective and safer.

New devices may treat heart failure more effectively than drugs.

Tofacitinib improved hair loss and skin symptoms in a patient after secukinumab caused hair loss.

Drug repurposing finds new uses for old drugs quickly and cheaply.

KATP channel openers may cause peripheral edema by reducing lymphatic contractions and flow.

Continuous baricitinib is needed to keep hair regrowth in severe alopecia areata.

Both ruxolitinib and tofacitinib are effective and safe for treating severe alopecia areata, but relapses are common.

Oral isotretinoin and cyproterone compound are equally effective for treating acne in women with cutaneous hyperandrogenism.

Tofacitinib, a medication for arthritis, showed potential for treating severe hair loss in a small Brazilian case series, but more research is needed.

Targeted cancer therapies can cause new side effects, requiring careful monitoring and management to ensure patient safety.

A patient with alopecia had hair regrowth with tofacitinib but developed a skin reaction, choosing to continue the treatment despite the side effect.

New treatments may restore cancer-blocking proteins, slow prostate cancer, identify drug targets, and potentially regrow hair.

The trial on testosterone replacement therapy in older men faced concerns due to prostate cancer risk.

Compounds 15, 20, and 25 are strong inhibitors of human steroid 5α-reductase type 2.